Novartis launches novel treatment for adult patients with SPMS in Egypt
The event took place in cooperation with the MS Chapter of the…
Novartis reveals new hope with overall survival benefit for HR+/HER2- advanced breast cancer patients
“Breast cancer is the most common form of cancer among Egyptian women…
Breakthrough treatment from Novartis sparks new hope for HR+/HER2- advanced breast cancer patients
“Breast cancer is the most common form of cancer among Egyptian women,…
Novartis Egypt launches campaign to address critical risk of high blood cholesterol
46% of deaths in country caused by cardiovascular disease
Novartis remains committed to supporting Egypt’s COVID-19 fight
Pharmaceutical company announces formation of $40m global Novartis COVID-19 Response Fund
Novartis launches ‘Oncology On Air’ campaign for raising awareness on breast cancer
Breast cancer responsible for about 15% of deaths of tumours
Sales of pharmaceutical companies increase by EGP 10bn, growing by 31%
Factories’ revenues amounted to EGP 5bn in November, despite calls for raising…
Generic drug competition hits Novartis sales
The Swiss pharmaceutical giant Novartis has said its net profit slipped 3…
